UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Annals of oncology, 2019-04, Vol.30 (4), p.582-588

2019

Volltextzugriff (PDF)

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

Annals of oncology, 2018-10, Vol.29, p.viii464-viii464

2018

Volltextzugriff (PDF)

Efficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis

Annals of oncology, 2018-10, Vol.29, p.viii444-viii444

2018

Volltextzugriff (PDF)

Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma

Clinical radiology, 2011-03, Vol.66 (3), p.224-236

2011

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

Cancer chemotherapy and pharmacology, 2011-03, Vol.67 (3), p.657-666

2011

Volltextzugriff (PDF)

A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations

Investigational new drugs, 2014-10, Vol.32 (5), p.969-975

2014

Volltextzugriff (PDF)

Remote and Local SST Forcing in Shaping Asian-Australian Monsoon Anomalies

Journal of the Meteorological Society of Japan. Ser. II, 2005, Vol.83(2), pp.153-167

2005

Volltextzugriff (PDF)

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

Cancer, 1999-12, Vol.86 (11), p.2252-2258

1999

Volltextzugriff (PDF)

Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma

Annals of oncology, 2016-10, Vol.27, p.vi385-vi385

2016

Volltextzugriff (PDF)

A phase I study of decitabine with pegylated interferon alpha -2b in advanced melanoma: impact on DNA methylation and lymphocyte populations

Investigational new drugs, 2014-10, Vol.32 (5), p.969-975

2014

Volltextzugriff (PDF)

P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma

European journal of cancer (1990), 2015-07, Vol.51, p.e24-e24

2015

Volltextzugriff (PDF)

Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules

Annals of oncology, 2014-09, Vol.25, p.v1

2014

Volltextzugriff (PDF)

Renal cell carcinoma: A paradigm of lanthanic disease

American journal of clinical oncology, 1999-06, Vol.22 (3), p.223-231

1999

Volltextzugriff (PDF)

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A phase II study

Cancer, 2005-06, Vol.103 (12), p.2590-2597

2005

Volltextzugriff (PDF)

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3351-3356

2003

Volltextzugriff (PDF)

Clinical results using biochemotherapy as a standard of care in advanced melanoma

Melanoma research, 2002-08, Vol.12 (4), p.381-387

2002

Volltextzugriff (PDF)

Treatment of Malignant Pleural Effusions with Tunneled Long-term Drainage Catheters

Journal of vascular and interventional radiology, 2001-02, Vol.12 (2), p.201-208

2001

Volltextzugriff (PDF)

Treatment of metastatic melanoma in the brain with temozolomide and thalidomide

The lancet oncology, 2001-10, Vol.2 (10), p.634-635

2001

Volltextzugriff (PDF)

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide

Oncology (Williston Park, N.Y.), 2000-12, Vol.14 (12 Suppl 13), p.25

Hwu, W J

2000

Volltextzugriff (PDF)

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

Vaccine, 2004-07, Vol.22 (21), p.2904-2909

2004

Volltextzugriff (PDF)

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

Journal of clinical oncology, 2002-06, Vol.20 (11), p.2610-2615

2002

Volltextzugriff (PDF)

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

Melanoma research, 2012-08, Vol.22 (4), p.310-315

2012

Volltextzugriff (PDF)

Systemic Chemotherapy

Clinics in plastic surgery, 2000-07, Vol.27 (3), p.451-461

2000

Volltextzugriff (PDF)

1301TiPA phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma

Annals of oncology, 2020-09, Vol.31, p.S762-S763

2020

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(121)
Tagungsberichte
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Humans
(69)
Life Sciences & Biomedicine
(59)
Male
(48)
Female
(47)
Biological And Medical Sciences
(39)
Medical Sciences
(36)
Adult
(33)
Middle Aged
(32)
Oncology
(24)
Schizophrenia
(24)
Aged
(18)
Psychiatry
(18)
Schizophrenia - Genetics
(18)
Technology
(15)
Melanoma - Pathology
(14)
Psychology. Psychoanalysis. Psychiatry
(14)
Adolescent
(13)
Dermatology
(13)
Melanoma - Drug Therapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

Efficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis

Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations

Remote and Local SST Forcing in Shaping Asian-Australian Monsoon Anomalies

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma

A phase I study of decitabine with pegylated interferon alpha -2b in advanced melanoma: impact on DNA methylation and lymphocyte populations

P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma

Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules

Renal cell carcinoma: A paradigm of lanthanic disease

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A phase II study

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Clinical results using biochemotherapy as a standard of care in advanced melanoma

Treatment of Malignant Pleural Effusions with Tunneled Long-term Drainage Catheters

Treatment of metastatic melanoma in the brain with temozolomide and thalidomide

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

Systemic Chemotherapy

1301TiPA phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma

Suchergebnisse filtern